+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07863323

Non-Invasive Hemodynamic Monitoring Using NICaS to Guide Fluid and Vasopressor Therapy Compared to Standard Care in Sepsis Patients Admitted to Medical Wards

Led by Regione del Veneto - AULSS n. 7 Pedemontana · Updated on 2026-10-07

430

Participants Needed

2

Research Sites

4 weeks

Total Duration

AI-Summary

What This Trial Is About

Sepsis affects millions worldwide each year and remains a leading cause of death despite medical advances. Early and effective treatment is crucial, especially managing fluids and blood pressure. This trial evaluates whether a personalized treatment strategy guided by non-invasive hemodynamic monitoring using the NICaS device improves survival compared to the standard fluid therapy recommended by international sepsis guidelines. Participants are randomly assigned to either a usual-care group receiving fluid resuscitation and vasopressors based on standard clinical signs or to a group guided by NICaS monitoring. The NICaS device measures heart and circulation parameters non-invasively, helping tailor fluid and vasopressor therapy. Fluid challenges and repeated assessments every three hours during the first 12 hours guide treatment adjustments in the NICaS group, while the usual-care group follows standard protocols. Participants will be monitored closely during their hospital stay and for 30 days after enrollment. Assessments include vital signs, fluid intake and output, blood tests, organ function scores, and clinical status. Researchers will compare survival rates, organ support needs, vasopressor use, kidney function, fluid balance, and predict patient outcomes using hemodynamic data combined with common scoring systems. The study aims to determine if this approach can lead to faster stabilization and better outcomes for septic patients.

CONDITIONS

Brief Title

Non-invasive Hemodynamic Optimization of Sepsis in Internal Medicine: a Randomized Study Comparing Therapy Guided by Non-invasive Hemodynamic Indices Versus Standard of Care.

Research Team

M

Massimo Marchetti, Dr.

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here